Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
Hydroxylation of the HIV-1 antisense protein promotes immune evasion of HIV-1 via modulation of TBK1
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 13 April 2026

Hydroxylation of the HIV-1 antisense protein promotes immune evasion of HIV-1 via modulation of TBK1

  • Xinguang Lin1,
  • Wenrui Zhang1,
  • Manman Li2,
  • Chuanzhen Zhang1,
  • Jingna Xun1,
  • Wendong Han3,
  • Jun Chen1,
  • Yihua Zhang1 &
  • …
  • Dapeng Yan  ORCID: orcid.org/0000-0002-1977-89771 

Nature Communications , Article number:  (2026) Cite this article

  • 1395 Accesses

  • 4 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • HIV infections
  • Infection
  • Innate immunity
  • Retrovirus

Abstract

HIV-1 evades host immunity via a number of virally encoded mediators. Here we show that the HIV-1 antisense protein (ASP) evades host immunity by interfering with the type I interferon (IFN-I) response. Mechanistically, host prolyl hydroxylase 3 (PHD3) hydroxylates ASP at Pro47, enabling the recruitment of the RING finger protein 114 (RNF114) to TANK-binding kinase 1 (TBK1). Subsequently, RNF114 mediates K6-linked ubiquitination of TBK1 at Lys236, suppressing TBK1 activation and the downstream IFN-I response. Conversely, mutation of ASP at Pro47 abolishes this inhibitory effect. In humanized mice, either ASP deletion or treatment with the RNF114 inhibitor EN219 or the PHD3 inhibitor Molidustat enhances antiviral immunity and reduces viral replication. Clinically, RNF114 and PHD3 transcript levels exhibit a positive correlation with viral load in treatment-naive patients. Here we show a distinct HIV-1 immune evasion mechanism involving proline hydroxylation and K6-linked ubiquitination, highlighting therapeutic potential.

Similar content being viewed by others

The translational landscape of HIV-1 infected cells reveals key gene regulatory principles

Article Open access 15 January 2025

Characterization of transmitted drug resistance among recently infected HIV-1 men who have sex with men in Hebei Province, China

Article Open access 11 November 2025

Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC

Article Open access 28 January 2022

Data availability

The RNA-seq data generated in this study have been deposited in the Sequence Read Archive (SRA) database under accession codes PRJNA1417155 and PRJNA1417156. The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium with the dataset identifier PXD073921. All newly generated materials in this study are available from the corresponding author upon request. All data necessary for confirming the conclusions of the article are present within the article or the Supplementary information. Source data are provided in this paper.

References

  1. Gallo, R. C. HIV/AIDS Research for the future. Cell Host Microbe 27, 499–501 (2020).

    Google Scholar 

  2. Siddiqui, M. A. & Yamashita, M. Toll-like receptor (TLR) signaling enables cyclic GMP-AMP synthase (cGAS) sensing of HIV-1 infection in macrophages. mBio 12, e0281721 (2021).

    Google Scholar 

  3. Cai, B., Wu, J., Yu, X., Su, X. Z. & Wang, R. F. FOSL1 inhibits type I interferon responses to malaria and viral infections by blocking TBK1 and TRAF3/TRIF interactions. mBio 8, https://doi.org/10.1128/mbio.02161-16 (2017).

  4. Hopfner, K. P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501–521 (2020).

    Google Scholar 

  5. Zhang, X., Bai, X. -c & Chen, Z. J. Structures and mechanisms in the cGAS-STING innate immunity pathway. Immunity 53, 43–53 (2020).

    Google Scholar 

  6. Gondim, M. V. P. et al. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Sci. Transl. Med. 13, https://doi.org/10.1126/scitranslmed.abd8179 (2021).

  7. Liu, H. et al. HIV infection suppresses TLR3 activation-mediated antiviral immunity in microglia and macrophages. Immunology 160, 269–279 (2020).

    Google Scholar 

  8. Evans, D. T. et al. N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages. PLOS Pathog. 17, e1009421 (2021).

  9. Nevels, M. et al. Disruption of type I interferon induction by HIV infection of T cells. Plos ONE 10, e0137951 (2015).

  10. Dhamanage, A., Thakar, M. & Paranjape, R. Human immunodeficiency virus-1 Impairs IFN-Alpha Production Induced by TLR-7 Agonist in Plasmacytoid Dendritic Cells. Viral Immunol. 30, 28–34 (2017).

    Google Scholar 

  11. Harman, A. N. et al. HIV blocks interferon induction in human dendritic cells and macrophages by dysregulation of TBK1. J. Virol. 89, 6575–6584 (2015).

    Google Scholar 

  12. Nan, Y., Wu, C. & Zhang, Y.-J. Interplay between janus kinase/signal transducer and activator of transcription signaling activated by type I interferons and viral antagonism. Front. Immunol. 8, https://doi.org/10.3389/fimmu.2017.01758 (2017).

  13. Savoret, J., Mesnard, J. M., Gross, A. & Chazal, N. Antisense transcripts and antisense protein: a new perspective on human immunodeficiency virus type 1. Front. Microbiol. 11, 625941 (2020).

    Google Scholar 

  14. Affram, Y. et al. The HIV-1 antisense protein ASP is a transmembrane protein of the cell surface and an integral protein of the viral envelope. J. Virol. 93, https://doi.org/10.1128/jvi.00574-19 (2019).

  15. Bet, A. et al. The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection. Retrovirology 12, https://doi.org/10.1186/s12977-015-0135-y (2015).

  16. Pavesi, A. & Romerio, F. Creation of the HIV-1 antisense gene asp coincided with the emergence of the pandemic group M and is associated with faster disease progression. Microbiol. Spectr. 12, e0380223 (2024).

    Google Scholar 

  17. Gholizadeh, Z., Iqbal, M. S., Li, R. & Romerio, F. The HIV-1 antisense gene ASP: the new kid on the block. Vaccines 9, https://doi.org/10.3390/vaccines9050513 (2021).

  18. Zapata, J. C. et al. The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly. Virology 506, 34–44 (2017).

    Google Scholar 

  19. Abe, T. & Barber, G. N. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-kappaB activation through TBK1. J. Virol. 88, 5328–5341 (2014).

    Google Scholar 

  20. Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903–906 (2013).

    Google Scholar 

  21. Izumida, M., Togawa, K., Hayashi, H., Matsuyama, T. & Kubo, Y. Production of vesicular stomatitis virus glycoprotein-pseudotyped lentiviral vector is enhanced by ezrin silencing. Front. Bioeng. Biotechnol. 8, https://doi.org/10.3389/fbioe.2020.00368 (2020).

  22. Clerc, I. et al. Polarized expression of the membrane ASP protein derived from HIV-1 antisense transcription in T cells. Retrovirology 8, https://doi.org/10.1186/1742-4690-8-74 (2011).

  23. Hesselman, M. C. et al. Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development. Cell Host Microbe 33, 279–293 (2025).

    Google Scholar 

  24. Caetano, D. G. et al. Patterns of diversity and humoral immunogenicity for HIV-1 antisense protein (ASP). Vaccines 12, 771 (2024).

  25. Larabi, A. et al. Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Rep. 3, 734–746 (2013).

    Google Scholar 

  26. Song, G. et al. E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1. Nat. Immunol. 17, 1342–1351 (2016).

    Google Scholar 

  27. Michel, M. A., Swatek, K. N., Hospenthal, M. K. & Komander, D. Ubiquitin linkage-specific affimers reveal insights into K6-linked ubiquitin signaling. Mol. Cell 68, 233–246 (2017).

    Google Scholar 

  28. Lee, S. B. et al. Proline hydroxylation primes protein kinases for autophosphorylation and activation. Mol. Cell 79, 376–389 (2020).

    Google Scholar 

  29. Semenza, G. L. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107, 1–3 (2001).

    Google Scholar 

  30. Rajashekar, J. K. et al. Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir. Cell Host Microbe 29, 904–916 (2021).

    Google Scholar 

  31. Vabret, N. et al. Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1. iScience 25, 104599 (2022).

  32. Yin, X. et al. Sensor sensibility—HIV-1 and the innate immune response. Cells 9, https://doi.org/10.3390/cells9010254 (2020).

  33. Fonseca, D., Pisanelli, G., Seoane, R., Miorin, L. & García-Sastre, A. TRIM65 regulates innate immune signaling by enhancing K6-linked ubiquitination of IRF3 and its chromatin recruitment. Cell Rep. 43, 114960 (2024).

  34. Yang, B. et al. RNF144A promotes antiviral responses by modulating STING ubiquitination. EMBO Rep.24, https://doi.org/10.15252/embr.202357528 (2023).

  35. Guo, J. et al. A genome-wide base-editing screen uncovers a pivotal role of paxillin δ ubiquitination in influenza virus infection. Cell Rep. 44, 115748 (2025).

  36. Strowitzki, M., Cummins, E. & Taylor, C. Protein hydroxylation by hypoxia-inducible factor (HIF) hydroxylases: unique or ubiquitous? Cells 8, 384 (2019).

  37. Duette, G. et al. Induction of HIF-1α by HIV-1 infection in CD4 + T cells promotes viral replication and drives extracellular vesicle-mediated inflammation. mBio 9, https://doi.org/10.1128/mbio.00757-18 (2018).

  38. Porter, K. M. et al. Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development. Pulm. Circul. 3, 58–67 (2013).

    Google Scholar 

  39. Saksela, K. Interactions of the HIV/SIV pathogenicity factor Nef with SH3 domain-containing host cell proteins. Curr. HIV Res. 9, 531–542 (2011).

    Google Scholar 

  40. Cassan, E., Arigon-Chifolleau, A.-M., Mesnard, J.-M., Gross, A. & Gascuel, O. Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic. Proc. Natl. Acad. Sci. USA 113, 11537–11542 (2016).

    Google Scholar 

  41. Kirchhoff, F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8, 55–67 (2010).

    Google Scholar 

  42. Sauter, D. et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6, 409–421 (2009).

    Google Scholar 

  43. Doyle, T., Goujon, C. & Malim, M. H. HIV-1 and interferons: who’s interfering with whom?. Nat. Rev. Microbiol. 13, 403–413 (2015).

    Google Scholar 

  44. Huang, X., Liu, Y., Ling, G. & Cao, X. Mitochondrial Lon protease promotes CD4+ T cell activation by activating the cGAS-STING-TBK1 axis in systemic lupus erythematosus. Int. Immunopharmacol. 123, https://doi.org/10.1016/j.intimp.2023.110519 (2023).

  45. Yu, J. et al. Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nat. Commun. 6, https://doi.org/10.1038/ncomms7074 (2015).

  46. Fukasaku, Y. et al. Novel immunological approach to asses donor reactivity of transplant recipients using a humanized mouse model. Hum. Immunol. 81, 342–353 (2020).

    Google Scholar 

  47. Lubow, J. et al. Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages. Elife 9, https://doi.org/10.7554/elife.51035 (2020).

  48. Iwamura, T. et al. Induction of IRF-3/-7 kinase and NF-κB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6, 375–388 (2001).

    Google Scholar 

  49. Wang, Y. et al. Decreased expression of the host long-noncoding RNA-GM facilitates viral escape by inhibiting the kinase activity TBK1 via S-glutathionylation. Immunity 53, 1168–1181 (2020).

    Google Scholar 

  50. Mijit, A. et al. Mapping synthetic binding proteins epitopes on diverse protein targets by protein structure prediction and protein-protein docking. Comput. Biol. Med. 163, 107183 (2023).

  51. Yan, Y., Tao, H., He, J. & Huang, S.-Y. The HDOCK server for integrated protein–protein docking. Nat. Protoc. 15, 1829–1852 (2020).

    Google Scholar 

  52. Yan, Y., Zhang, D., Zhou, P., Li, B. & Huang, S.-Y. HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy. Nucleic Acids Res. 45, W365–W373 (2017).

    Google Scholar 

Download references

Acknowledgements

We thank Dr. B. Ge (Tongji University, Shanghai, China) for generously providing the expression constructs Flag-N-RIG-I, Flag-TBK1, Flag-IRF3-5D, Flag-cGAS, and Flag-STING. We are also grateful to Dr. D. Sauter (Ulm University, Meierhof-strasse, Germany) for providing the plasmids pYU2, pNL4-3 and VSV-G-pseudotyped NL4.3-Δenv used in this study. The study was supported by a grant from the Shanghai Pilot Program for Basic Research - Fudan University (21TQ1400100), the National Natural Science Foundation of China (32270973, 32572032, 32571090), the National Natural Science Foundation Youth Program (32301986), the Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project (2025ZD01904400), the Shuguang Program of Shanghai Education Development Foundation, Shanghai Municipal Education Commission, In-hospital Research Project of Shanghai Public Health Clinical Center (KY-GW-2024-14).

Author information

Authors and Affiliations

  1. Shanghai Institute of Infectious Disease and Biosecurity, Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

    Xinguang Lin, Wenrui Zhang, Chuanzhen Zhang, Jingna Xun, Jun Chen, Yihua Zhang & Dapeng Yan

  2. Ningbo Research Institute, Fudan University, Ningbo, China

    Manman Li

  3. Biosafety Level 3 Laboratory, Fudan University, Shanghai, China

    Wendong Han

Authors
  1. Xinguang Lin
    View author publications

    Search author on:PubMed Google Scholar

  2. Wenrui Zhang
    View author publications

    Search author on:PubMed Google Scholar

  3. Manman Li
    View author publications

    Search author on:PubMed Google Scholar

  4. Chuanzhen Zhang
    View author publications

    Search author on:PubMed Google Scholar

  5. Jingna Xun
    View author publications

    Search author on:PubMed Google Scholar

  6. Wendong Han
    View author publications

    Search author on:PubMed Google Scholar

  7. Jun Chen
    View author publications

    Search author on:PubMed Google Scholar

  8. Yihua Zhang
    View author publications

    Search author on:PubMed Google Scholar

  9. Dapeng Yan
    View author publications

    Search author on:PubMed Google Scholar

Contributions

X.L. and D.Y. designed this study; X.L. performed the experiments, assisted by W.Z., M.L., C.Z., J.X., and W.H.; J.C., Y.Z., and X.L. contributed to discussions and agreement with the conclusions; X.L. and D.Y. analyzed the data and wrote the manuscript; and all authors discussed the results and commented on the manuscript.

Corresponding author

Correspondence to Dapeng Yan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information (download PDF )

Reporting Summary (download PDF )

Transparent Peer Review file (download PDF )

Source data

Source Data (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, X., Zhang, W., Li, M. et al. Hydroxylation of the HIV-1 antisense protein promotes immune evasion of HIV-1 via modulation of TBK1. Nat Commun (2026). https://doi.org/10.1038/s41467-026-71807-z

Download citation

  • Received: 02 October 2025

  • Accepted: 30 March 2026

  • Published: 13 April 2026

  • DOI: https://doi.org/10.1038/s41467-026-71807-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing